Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial

✍ Scribed by Mannelli, Paolo; Wu, Li-Tzy; Peindl, Kathleen S.; Swartz, Marvin S.; Woody, George E.

• Book ID: 122265851
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 436 KB
• Volume: 138
• Category: Article
• ISSN: 0376-8716
• DOI: 10.1016/j.drugalcdep.2014.02.002